GOLDMAN SACHS GROUP INC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$351,450
-85.4%
407,289
-54.2%
0.00%
Q2 2023$2,399,655
-76.9%
888,761
+59.4%
0.00%
-100.0%
Q1 2023$10,407,056
+46.5%
557,720
+25.8%
0.00%0.0%
Q4 2022$7,101,425
-13.0%
443,285
-29.4%
0.00%0.0%
Q3 2022$8,164,000
+5.0%
627,539
-14.8%
0.00%0.0%
Q2 2022$7,777,000
-4.3%
736,550
+8.9%
0.00%0.0%
Q1 2022$8,126,000
-42.9%
676,068
-33.0%
0.00%
-33.3%
Q4 2021$14,237,000
+54.3%
1,009,676
+11.8%
0.00%
+50.0%
Q3 2021$9,229,000
-54.5%
903,022
+18.6%
0.00%
-60.0%
Q2 2021$20,280,000
-35.4%
761,539
-15.7%
0.01%
-37.5%
Q1 2021$31,370,000
-16.4%
903,780
-10.7%
0.01%
-20.0%
Q4 2020$37,524,000
-9.0%
1,011,703
+0.9%
0.01%
-9.1%
Q3 2020$41,237,000
-6.9%
1,002,876
-8.2%
0.01%
-15.4%
Q2 2020$44,290,000
+19.0%
1,092,768
+2.0%
0.01%0.0%
Q1 2020$37,231,000
-17.2%
1,071,394
+2.2%
0.01%
+18.2%
Q4 2019$44,968,000
+39.1%
1,048,453
+20.0%
0.01%
+22.2%
Q3 2019$32,318,000
+5.7%
873,935
+29.2%
0.01%0.0%
Q2 2019$30,568,000
-27.1%
676,581
-12.3%
0.01%
-30.8%
Q1 2019$41,920,000
+19.6%
771,297
+1.9%
0.01%
+18.2%
Q4 2018$35,038,000
+13.4%
757,086
+48.8%
0.01%
+37.5%
Q3 2018$30,910,000
-33.7%
508,811
-31.7%
0.01%
-38.5%
Q2 2018$46,614,000
+50.4%
744,639
+11.0%
0.01%
+62.5%
Q1 2018$31,000,000
+28.5%
670,989
+31.9%
0.01%
+33.3%
Q4 2017$24,120,000
-32.4%
508,869
-23.3%
0.01%
-33.3%
Q3 2017$35,691,000
+124.0%
663,394
+34.5%
0.01%
+200.0%
Q2 2017$15,936,000
+111.4%
493,372
+61.3%
0.00%
+50.0%
Q1 2017$7,538,000
+70.4%
305,786
+48.0%
0.00%
+100.0%
Q4 2016$4,423,000
+53.4%
206,674
+48.4%
0.00%0.0%
Q3 2016$2,883,000
-78.6%
139,302
-83.0%
0.00%
-75.0%
Q2 2016$13,467,000
-30.5%
820,692
-9.8%
0.00%
-20.0%
Q1 2016$19,378,000
+58.0%
910,182
+126.1%
0.01%
+25.0%
Q4 2015$12,265,000
+51.3%
402,508
+8.8%
0.00%
+33.3%
Q3 2015$8,108,000
+103.9%
369,898
+118.6%
0.00%
+200.0%
Q2 2015$3,977,000
-75.1%
169,238
-66.8%
0.00%
-80.0%
Q1 2015$15,994,000
+22.0%
509,695
+6.3%
0.01%
+25.0%
Q4 2014$13,105,000479,3070.00%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 195,707$168,8760.11%
ARMISTICE CAPITAL, LLC 7,892,000$6,810,0070.10%
Nan Fung Group Holdings Ltd 62,106$53,5910.04%
XTX Topco Ltd 174,496$150,5730.03%
BHK Investment Advisors, LLC 57,625$49,7250.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,557,128$2,206,5460.01%
FOX RUN MANAGEMENT, L.L.C. 42,720$36,8630.01%
PRIMECAP MANAGEMENT CO/CA/ 14,724,968$12,706,1750.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 38,634$4,0020.01%
Point72 Middle East FZE 342,385$295,4440.01%
View complete list of FIBROGEN INC shareholders